Related Experiment Videos
Associations between eNOS polymorphisms and susceptibility to Behcet's disease: a meta-analysis
1Division of Rheumatology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea. lyhcgh@korea.ac.kr
Summary
This meta-analysis found no significant link between endothelial nitric oxide synthase (eNOS) gene polymorphisms and Behcet's disease (BD) in Turkish and Asian populations. These specific eNOS variants do not appear to increase susceptibility to BD in these ethnic groups.
Area of Science:
- Genetics
- Immunology
- Molecular Biology
Background:
- Behcet's disease (BD) is a chronic inflammatory disorder of unknown etiology.
- Genetic factors are implicated in BD susceptibility, with various gene polymorphisms investigated.
- Endothelial nitric oxide synthase (eNOS) plays a role in vascular function and inflammation.
Purpose of the Study:
- To investigate the association between endothelial nitric oxide synthase (eNOS) gene polymorphisms (G894T and 4b/a) and Behcet's disease (BD) susceptibility.
- To perform a comprehensive meta-analysis of existing studies examining eNOS polymorphisms in BD patients and healthy controls.
Main Methods:
- A systematic meta-analysis was conducted, pooling data from multiple studies.
- The analysis included eight studies comprising 841 BD cases and 866 controls.
- Associations were assessed using allele contrast, recessive, dominant, and additive genetic models.
Main Results:
- The meta-analysis revealed no significant association between the eNOS G894T polymorphism and BD across all populations studied.
- No association was found between the eNOS 4b/a polymorphism and BD in any of the populations analyzed.
- While one Tunisian study suggested an association for the G894T T allele, this finding was not consistent across ethnic groups, with conflicting results in European populations.
Conclusions:
- The eNOS G894T and 4b/a polymorphisms are not significantly associated with Behcet's disease in Turkish and Asian populations.
- These findings suggest that these specific eNOS polymorphisms do not confer susceptibility to BD in these ethnic groups.
- Further research may be needed to explore other genetic factors contributing to BD pathogenesis in diverse populations.
Related Concept Videos
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:05Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...